Advertisement

Author: Reuters

FDA declines to approve Allergan’s Esmya

(Reuters) – Allergan Plc said on Tuesday U.S. health regulators had declined to approve Esmya, its treatment for abnormal uterine bleeding in women with uterine fibroids, requesting more information and citing safety...

Read More

Consumer baby monitors may get vital signs wrong

By Linda Carroll (Reuters Health) – Two popular monitors that promise to keep parents informed about their babies’ vital signs scored poorly in a test comparing them with actual hospital quality monitors, researchers...

Read More

Most parents are against teen tattoos

By Linda Carroll (Reuters Health) – Parents who’ve said “no” to teen tattoos need not feel alone. A new U.S. survey finds that 78 percent of parents wouldn’t even consider allowing their teenager to...

Read More

For latest news and updates
Email-id is invalid